Immunogenicity and Reactogenicity of DTPa-IPV/Hib Vaccine Co-administered With Hepatitis B Vaccine for Primary and Booster Vaccination of Taiwanese Infants

Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (Hib) conjugate vaccine (DTPa-IPV/Hib, Infanrix™-IPV + Hib) was assessed when co-administered with hepatitis B (HBV) vaccine. Seventy healthy infants received...

Full description

Bibliographic Details
Published in:	Journal of the Formosan Medical Association
Main Authors:	Pei-Lan Shao, Chun-Yi Lu, Yu-Chia Hsieh, Hans L Bock, Li-Min Huang
Format:	Article
Language:	English
Published:	Elsevier 2011-06-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664611600612

Similar Items

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
by: Sanjay K. Lalwani, et al.
Published: (2017-01-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019-02-01)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
by: Julianne Bayliss, et al.
Published: (2021-01-01)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017-03-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
by: Victor Romanenko, et al.
Published: (2020-09-01)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
by: Marina George, et al.
Published: (2023-01-01)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
by: Timo Vesikari, et al.
Published: (2017-07-01)

Immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type B conjugate vaccine (PRP-T) for primary and booster vaccinations
by: Humberto Bracco Neto, et al.

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines
by: Hee-Jin Kim, et al.
Published: (2024-06-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021-01-01)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
by: Yuntao Zhang, et al.
Published: (2022-12-01)

Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01)

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017-02-01)

Immunogenicity and Reactogenicity of Diphtheria—Tetanus—Acellular Pertussis—Hepatitis B—Inactivated Poliovirus and Haemophilus influenzae Type B Vaccines Administered Concomitantly to Infants as a Three-dose Primary Course
by: Pei-Lan Shao, et al.
Published: (2011-05-01)

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
by: Hitt Sharma, et al.
Published: (2024-02-01)

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
by: Tino F. Schwarz, et al.
Published: (2019-01-01)

Methods for predicting vaccine immunogenicity and reactogenicity
by: Patrícia Gonzalez-Dias, et al.
Published: (2020-02-01)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024-12-01)

Comparative safety evaluation of pentavalent (DTaP-IPV-Hib) and hexavalent (DTaP-IPV-Hib-HepB) vaccines in infants: a real-world analysis based on VAERS
by: Zhen Wei, et al.
Published: (2025-10-01)

Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population
by: Prasert Assantachai, et al.
Published: (2024-01-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
by: Alycia P. Fratzke, et al.
Published: (2022-05-01)

Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts
by: Hyun Myung Kang, et al.
Published: (2025-07-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
by: Zhen-jiang LIU, et al.
Published: (2022-02-01)

Preclinical Immunogenicity Evaluation of a DTacP-sIPV/Hib Combination Vaccine in Rodent Models Under Varying Formulations and Immunization Schedules
by: Yixian Fu, et al.
Published: (2025-09-01)

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
by: Asmik Asatryan, et al.
Published: (2021-03-01)

Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chenchit Chayachinda, et al.
Published: (2023-08-01)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
by: Jisun Lee, et al.
Published: (2023-07-01)

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023-12-01)

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule
by: Collard Alix, et al.
Published: (2010-10-01)

Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school childrenResearch in context
by: Nginache Nampota-Nkomba, et al.
Published: (2025-03-01)

Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia
by: Maja Stosic, et al.
Published: (2022-05-01)

CDKL5 deficiency disorder in an infant presenting as drug-refractory epilepsy after TdaP-Hib-IPV vaccination: A case report
by: Hong-Yu Chen, et al.
Published: (2025-01-01)

Lagging Immune Response to <i>Haemophilus influenzae</i> Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
by: Leo Schouls, et al.
Published: (2020-06-01)

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
by: Alberto San Francisco Ramos, et al.
Published: (2024-12-01)

Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial
by: Oana Falup-Pecurariu, et al.
Published: (2017-03-01)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
by: Stilla Bauernfeind, et al.
Published: (2021-09-01)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
by: Yufei Wu, et al.
Published: (2023-07-01)

Occurrence of Haemophilus influenzae type b (Hib) meningitis in a 2 month-old infant in the Hib vaccination era
by: Yoshiaki Cho, et al.
Published: (2022-06-01)